XFOR X4 Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$2,83
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,75rendah 52m
$4,83tinggi 52m
Kapitalisasi Pasar (MRQ)
$272M
P/E (TTM)
2.2
EPS (TTM)
$1.27
Pendapatan (TTM)
$9M
lencana Anda
Rentang 52M
$3–$5
Peringkat Analis
STRONG BUY
Target Harga
$12
P/E
2.2
ROE
-113.1%
Margin Laba Bersih
-1029.4%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
XFOR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$2.83
Kapitalisasi Pasar (MRQ)
$272M
P/E (TTM)
2.2
EPS (TTM)
$1.27
Pendapatan (TTM)
$9M
ROE (TTM)
-113.1%
Rentang 52M
$3–$5
XFOR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 28 April 2025 | 1-for-30 | Terbalik |
| 14 Maret 2019 | 1-for-6 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$6M2018-12-31 → 2025-12-31
EPS$-1.872020-12-31 → 2025-12-31
Arus Kas Bebas$-86M2018-12-31 → 2025-12-31
Margin bersih-1029.4%2018-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | XFOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 2.2rata-rata 5T ≈-8.9 | ≈-8.9 | · | · | |
| P/S (TTM) | 31.1 | · | 25.4 | Terlalu mahal | |
| P/B (MRQ) | 1.7rata-rata 5T ≈66.7 | ≈66.7 | 2.9 | Nilai wajar | |
| Price / FCF (Harga / FCF) | -3.0rata-rata 5T ≈-30.1 | ≈-30.1 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -3.0rata-rata 5T ≈-30.2 | ≈-30.2 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 1.9rata-rata 5T ≈58.0 | ≈58.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | XFOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -1003.9% | · | -397.9% | Lemah | |
| Margin EBITDA (TTM) | -984.9% | · | -397.9% | Lemah | |
| Margin Sebelum Pajak (TTM) | -1029.8% | · | -482.4% | Lemah | |
| Margin Laba Bersih (TTM) | -1029.4% | · | -355.9% | Lemah | |
| ROA (TTM) | -50.3%rata-rata 5T ≈-54.3% | ≈-54.3% | -45.0% | Tingkat teratas | |
| ROE (TTM) | -113.1%rata-rata 5T ≈-123.4% | ≈-123.4% | -68.7% | Lemah | |
| ROIC | -46.7%rata-rata 5T ≈-96.4% | ≈-96.4% | -45.0% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | XFOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 11.3rata-rata 5T ≈6.2 | ≈6.2 | 7.8 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 8.4rata-rata 5T ≈5.2 | ≈5.2 | 3.9 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | XFOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 150.0% | · | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 16.7% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | XFOR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.0 | ≈0.0 | 0.2 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 7.9 | · | 6.5 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$144.4K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
32.2%
Laporan Berikutnya
Nov 03, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $-0.13 | $-0.18 | 29.2% |
| 31 Maret 2026 | $-0.16 | $-0.20 | 21.6% | |
| 31 Des. 2025 | $-0.22 | $-0.35 | 37.9% | |
| 30 Sep. 2025 | $-0.69 | $-0.93 | 26.1% | |
| 30 Juni 2025 | $-3.47 | $-4.42 | 21.6% | |
| 31 Maret 2025 | $0.04 | $-4.53 | 100.9% | |
| 31 Des. 2024 | $-6.00 | $-5.36 | -12.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.05 | $0.13 | $0.31 | $0.61 | $2.29 | $4.46 | $8.01 | $1.48 | |
| Revenue / Share | $0.15 | $0.01 | · | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-2.02 | $-0.65 | $-0.54 | $-1.21 | · | · | · | · | |
| Cash / Share | $2.39 | $0.33 | $0.59 | $1.00 | $2.91 | $4.83 | $7.82 | $2.11 | |
| EPS (TTM) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | · | 43,272,773 | 7,412,990 | 6,840,035 | · | 6,695,509 | 6,681,349 | 6,666,386 | · | 196,987,827 | 168,737,764 | 145,967,476 | · | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | · | 43,272,773 | 7,412,990 | 6,869,084 | · | 6,695,509 | 6,693,376 | 6,666,386 | · | 196,987,827 | 168,737,764 | 145,967,476 | · | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.62 | $1.79 | · | $2.45 | $0.50 | $3.96 | · | $0.35 | $0.56 | $0.01 | · | $0.41 | · | · | · | $0.90 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.04 | $0.24 | $0.13 | · | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-1.80 | · | · | $-0.32 | $-0.17 | · | $-0.35 | $-0.28 | $-0.18 | · | · | |
| Cash / Share | $2.03 | $2.30 | · | $2.77 | $4.93 | $6.95 | · | $0.58 | $0.88 | $0.36 | · | $0.80 | · | · | · | $1.16 | |
| EPS (TTM) | $1.27 | $-2.07 | · | $-10.03 | $-14.82 | $2.22 | · | $-16.25 | $-10.78 | $-24.68 | · | $-0.44 | $-0.69 | $-0.96 | · | $-2.86 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $8M | · | $6M | $5M | $4M | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-90M | $-100M | · | $-95M | $-102M | $15M | · | $-17M | $18M | $-129M | · | $-111M | $-130M | $-96M | · | $-95M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | 3.7 | -2.0 | · | -0.3 | -0.1 | 3.2 | · | -1.2 | -1.6 | -1.7 | · | -74.3 | -84.3 | -27.2 | · | -17.9 | |
| P/S | 51.3 | 48.4 | · | 15.2 | 3.2 | 11.6 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| Earnings Yield | 27.2% | -50.1% | · | -293.3% | -780.0% | 31.4% | · | -81.0% | -62.0% | -59.2% | · | -1.4% | -1.2% | -3.7% | · | -5.6% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $6M | $3M | $0 | $0 | $0 |
| Margin Operasi % | -1336.7% | -1423.6% | · | · | · |
| Laba Bersih | $-79M | $-37M | $-101M | $-94M | $-89M |
| EPS Dilusian | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | · | · | 1.1 | 0.5 | 0.5 |
| Rasio Lancar | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| Rasio Cepat | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-86M | $-131M | $-97M | $-77M | $-72M |
Pemilik institusional (13F) 93 pengaju · $463.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
93
Nilai yang dipegang
$463.3M
Posisi baru
36
Posisi yang keluar
26
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 36 (+18 vs Kuartal sebelumnya) | 26 (+17 vs Kuartal sebelumnya) | 23 (+1 vs Kuartal sebelumnya) | 13 (-8 vs Kuartal sebelumnya) | +8.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MORGAN STANLEY | $44.184.173 | 9.461.279 | 9,54% | Saham |
| FMR LLC | $38.862.138 | 8.321.657 | 8,39% | Saham |
| Bain Capital Life Sciences Investors, LLC | $37.208.011 | 7.967.454 | 8,03% | Saham |
| PERCEPTIVE ADVISORS LLC | $37.049.403 | 7.933.491 | 8,00% | Saham |
| Saturn V Capital Management LP | $32.565.512 | 6.973.343 | 7,03% | Saham |
| Empery Asset Management, LP | $32.365.860 | 6.930.591 | 6,99% | Saham |
| Deep Track Capital, LP | $27.453.795 | 5.878.757 | 5,93% | Saham |
| BlackRock, Inc. | $25.941.411 | 5.554.906 | 5,60% | Saham |
| Kalehua Capital Management LLC | $17.385.663 | 3.722.840 | 3,75% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.353.062 | 3.715.859 | 3,75% | Saham |
| Rosalind Advisors, Inc. | $15.012.957 | 3.214.766 | 3,24% | Saham |
| VANGUARD GROUP INC | $13.694.648 | 3.423.662 | 2,96% | Saham |
| BRAIDWELL LP | $13.649.261 | 2.922.754 | 2,95% | Saham |
| Blackstone Inc. | $12.524.576 | 2.681.922 | 2,70% | Saham |
| Trails Edge Capital Partners, LP | $12.008.803 | 2.571.478 | 2,59% | Saham |
| Nantahala Capital Management, LLC | $11.439.016 | 2.449.468 | 2,47% | Saham |
| BVF INC/IL | $10.431.575 | 2.233.742 | 2,25% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $9.800.562 | 2.098.047 | 2,12% | Saham |
| Venrock Adviser, LLC | $9.032.962 | 1.934.253 | 1,95% | Saham |
| SAMSARA BIOCAPITAL, LLC | $6.517.391 | 1.395.587 | 1,41% | Saham |
| STATE STREET CORP | $6.052.399 | 1.296.017 | 1,31% | Saham |
| Woodline Partners LP | $4.675.114 | 1.001.095 | 1,01% | Saham |
| GOLDMAN SACHS GROUP INC | $4.280.223 | 916.536 | 0,92% | Saham |
| NORTHERN TRUST CORP | $3.048.805 | 652.849 | 0,66% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.671.417 | 572.038 | 0,58% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.531.738 | 542.128 | 0,55% | Saham |
| Verdad Advisers, LP | $1.644.274 | 352.093 | 0,35% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.229.443 | 263.264 | 0,27% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.168.901 | 250.300 | 0,25% | Opsi beli |
| Caption Management, LLC | $1.167.500 | 250.000 | 0,25% | Opsi beli |
| Stonepine Capital Management, LLC | $1.050.699 | 224.989 | 0,23% | Saham |
| Bank of New York Mellon Corp | $916.908 | 196.340 | 0,20% | Saham |
| Affinity Asset Advisors, LLC | $677.150 | 145.000 | 0,15% | Saham |
| Nuveen, LLC | $501.507 | 107.389 | 0,11% | Saham |
| Invesco Ltd. | $451.926 | 96.772 | 0,10% | Saham |
| ALPS ADVISORS INC | $447.040 | 95.726 | 0,10% | Saham |
| RHUMBLINE ADVISERS | $444.022 | 95.081 | 0,10% | Saham |
| Susquehanna Portfolio Strategies, LLC | $407.607 | 87.282 | 0,09% | Saham |
| DEUTSCHE BANK AG\ | $368.393 | 78.885 | 0,08% | Saham |
| AMERICAN CENTURY COMPANIES INC | $349.293 | 74.795 | 0,08% | Saham |
| CITIGROUP INC | $327.423 | 70.112 | 0,07% | Saham |
| WELLS FARGO & COMPANY/MN | $316.215 | 67.712 | 0,07% | Saham |
| Palumbo Wealth Management LLC | $313.432 | 67.116 | 0,07% | Saham |
| Squarepoint Ops LLC | $313.254 | 67.078 | 0,07% | Saham |
| UBS Group AG | $271.060 | 58.043 | 0,06% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $241.906 | 51.800 | 0,05% | Saham |
| MetLife Investment Management, LLC | $224.015 | 47.969 | 0,05% | Saham |
| BANK OF AMERICA CORP /DE/ | $218.841 | 46.861 | 0,05% | Saham |
| Point72 Asset Management, L.P. | $191.806 | 41.072 | 0,04% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173.131 | 37.073 | 0,04% | Saham |
Aktivis & pemilik 5%+ 10 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 pengajuan | 29 Okt. 2025 | 6,20% | Amandemen | Investasi pasif | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 18 Agu 2025 | 9,99% | Pengajuan awal | · | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 13 Agu 2025 | 9,99% | Pengajuan awal | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 pengajuan | 17 Juli 2019 | · | Pengajuan awal | · | SEC |
| 28 Mei 2019 | · | Pengajuan awal | · | SEC | |
| Paula Ragan, Ph.D. ×2 pengajuan | 26 April 2019 | · | Pengajuan awal | M&A / penjualan | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 pengajuan | 19 Maret 2019 | · | Pengajuan awal | · | SEC |
| X4 Pharmaceuticals, Inc. | 6 Des. 2018 | · | Pengajuan awal | M&A / penjualan | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 14 Feb. 2018 | · | Pengajuan awal | Investasi pasif | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 29 Nov. 2017 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 39 orang dalam · 17 pejabat · 21 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 12 Feb. 2025 A | 3.337.386 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 27 Nov. 2018 A | 250.000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 30 Juni 2026 S | 167.750 | 0 | 2 | $-109.156 |
| Adam S. Mostafa | Chief Financial Officer | 12 Feb. 2025 A | 850.000 | 0 | 0 | $0 |
| John Volpone | President | 12 Agu 2026 S | 265.305 | 0 | 1 | $-109.117 |
| Mary Dibiase | Chief Operating Officer | 12 Feb. 2025 A | 1.140.980 | 0 | 0 | $0 |
| Adam R Craig | Executive Chairman | 12 Agu 2026 S | 328.651 | 0 | 1 | $-210.616 |
| Natasha Fay Thoren | Chief Legal Officer | 20 Mei 2025 A | 9.462 | 0 | 0 | $0 |
| Mark Baldry | Chief Commercial Officer | 16 Mei 2025 A | 25.337 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 12 Feb. 2025 A | 864.207 | 0 | 0 | $0 |
| Arthur Taveras | Chief Scientific Officer | 7 Okt. 2024 S | 388.026 | 0 | 0 | $0 |
| Derek M Meisner | Chief Legal Officer | 17 Agu 2022 S | 145.155 | 0 | 0 | $0 |
| Diego Cadavid | Chief Medical Officer | 1 Maret 2022 A | 104.107 | 0 | 0 | $0 |
| Renato Skerlj | Chief Scientific Officer | 9 Sep. 2020 S | 42.076 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 24 April 2019 A | · | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 7 Maret 2018 A | · | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 7 Maret 2018 A | · | 0 | 0 | $0 |
| Kelly Gold | Direktur | 1 Juli 2026 A | · | 0 | 0 | $0 |
| Francoise De Craecker | Direktur | 1 Jan. 2026 A | 4.722 | 0 | 0 | $0 |
| Murray Stewart | Direktur | 1 Jan. 2026 A | 7.883 | 0 | 0 | $0 |
| Gary Bridger | Direktur | 1 Jan. 2026 A | 4.722 | 0 | 0 | $0 |
| Michael S Wyzga | Direktur | 1 Jan. 2026 A | 5.555 | 0 | 0 | $0 |
| Keith Woods | Direktur | 9 Juni 2025 A | 6.000 | 0 | 0 | $0 |
| William Aliski | Direktur | 10 Juni 2024 A | 96.667 | 0 | 0 | $0 |
| Alison Frances Lawton | Direktur | 10 Juni 2024 A | 96.667 | 0 | 0 | $0 |
| David W J Mcgirr | Direktur | 10 Juni 2024 A | 96.667 | 0 | 0 | $0 |
| Rene Russo | Direktur | 2 Juni 2021 A | · | 0 | 0 | $0 |
| Isaac Blech | Direktur | 13 Maret 2019 A | · | 0 | 0 | $0 |
| Tillman U. Gerngross | Direktur | 5 Juni 2018 A | 392.821 | 0 | 0 | $0 |
| Claudio Nessi | Direktur | 5 Juni 2018 A | 867.639 | 0 | 0 | $0 |
| Amy Schulman | Direktur | 5 Juni 2018 A | · | 0 | 0 | $0 |
| William D Clark | Direktur | 5 Juni 2018 A | · | 0 | 0 | $0 |
| GORDON CARL L | Direktur | 5 Juni 2018 A | 1.868.966 | 0 | 0 | $0 |
| Terrance McGuire | Direktur | 5 Juni 2018 A | 18.031 | 0 | 0 | $0 |
| Michael Jay Ross | Direktur | 15 Nov. 2017 A | 1.868.961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | Pemilik 10% | 20 Nov. 2017 C | 124.381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | Pemilik 10% | 20 Nov. 2017 C | 722.179 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Pemilik 10% | 15 Nov. 2017 C | 225.680 | 0 | 0 | $0 |
| Anthony Chris Stevens | · | 7 Maret 2018 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 11 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,36% | 29.512 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,06% | 273.306 SH | 11 Sep. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70.293 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 38.483 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 464.950 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,01% | 2.014.836 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 48.548 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.031.672 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.599.387 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.885 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 753.604 SH | 11 Sep. 2026 | Harian |
XFOR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 11 analis
BELI
Target median
$12.00
+324,0%
5 45,5%
Beli Kuat
5 45,5%
Beli
1 9,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-09-29Target rata-rata $11.60 +309,9%
← Di bawah semua target
Harga saat ini $2.83
Rendah$10.00
Rata-rata$11.60
Tinggi$13.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026